Detalhe da pesquisa
1.
Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.
N Engl J Med
; 387(9): 810-823, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36053506
2.
Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid.
J Antimicrob Chemother
; 77(6): 1685-1693, 2022 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35260883
3.
Regimens for Drug-Resistant Tuberculosis. Reply.
N Engl J Med
; 388(2): 190-191, 2023 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630638
4.
A thorough QT study to evaluate the effects of therapeutic and supratherapeutic doses of delafloxacin on cardiac repolarization.
Antimicrob Agents Chemother
; 59(6): 3469-73, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25845864
5.
Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid.
PLOS Glob Public Health
; 3(10): e0002283, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37851685
6.
Community health workers and medicaid managed care in New Mexico.
J Community Health
; 37(3): 563-71, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21953498
7.
Leveraging longitudinal clinical laboratory results to improve prenatal care.
Am J Manag Care
; 27(2): 60-65, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33577153
8.
Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.
N Engl J Med
; 346(26): 2039-46, 2002 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-12087139
9.
Factors associated with risk of surgical wound infections.
Am J Med Qual
; 21(6 Suppl): 29S-34S, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17077416
10.
Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age.
Clin Ther
; 38(1): 39-52, 2016 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26581327
11.
Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers.
Clin Ther
; 38(1): 53-65, 2016 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26718605
12.
Analysis of the virological response with respect to baseline viral phenotype and genotype in protease inhibitor-experienced HIV-1-infected patients receiving lopinavir/ritonavir therapy.
Antivir Ther
; 7(3): 165-74, 2002 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12487383
13.
Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children.
Pediatr Infect Dis J
; 22(3): 216-24, 2003 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12634581
14.
Characterization of resistant HIV variants generated by in vitro passage with lopinavir/ritonavir.
Antiviral Res
; 59(3): 173-80, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12927307
15.
Cost-effectiveness of lopinavir/ritonavir versus nelfinavir as the first-line highly active antiretroviral therapy regimen for HIV infection.
HIV Clin Trials
; 5(5): 294-304, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15562370
16.
A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo.
J Virol
; 77(8): 5037-8, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12663814
17.
Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudine.
J Infect Dis
; 189(1): 51-60, 2004 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14702153
18.
Virtual inhibitory quotient predicts response to ritonavir boosting of indinavir-based therapy in human immunodeficiency virus-infected patients with ongoing viremia.
Antimicrob Agents Chemother
; 46(12): 3907-16, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12435695
19.
Determining the relative efficacy of highly active antiretroviral therapy.
J Infect Dis
; 187(6): 896-900, 2003 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12660935
20.
Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patients.
J Infect Dis
; 190(2): 280-4, 2004 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15216462